Sidley Austin advised PhaseV Trials Inc. on the transaction. PhaseV Trials Inc., a leader in AI/ML-driven clinical development, announced its US$50 million Series A financing round….
PhaseV’s $50 Million Series A Financing Round


Sidley Austin advised PhaseV Trials Inc. on the transaction. PhaseV Trials Inc., a leader in AI/ML-driven clinical development, announced its US$50 million Series A financing round….
…